The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer

被引:139
作者
Williams, A [1 ]
Sun, XY [1 ]
Fischer, JE [1 ]
Hasselgren, PO [1 ]
机构
[1] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA
关键词
D O I
10.1016/S0039-6060(99)70131-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The intracellular mechanisms of muscle cachexia in patients with cancer are not known. To assess the role of the ubiquitin-proteasome proteolytic pathway in cancer-induced muscle breakdown, we determined messenger RNA levels for ubiquitin and several 20S proteasome subunits in muscle from patients undergoing surgery for cancer. Methods: A biopsy specimen was obtained from the rectus abdominis muscle in patients undergoing laparotomy for cancer (n = 6) or noncancer disease (n = 6). Tissue levels of mRNA for ubiquitin and the 20S proteasome subunits HC3, HC5, HC7, and HC9 were determined by dot blot analysis. Results: The mRNA levels for ubiquitin and the 20S proteasome subunits were 2 to 4 times higher in muscle from patients with cancer than in muscle from control patients. Conclusion: This is the first report of increased expression of genes in the ubiquitin-proteasome proteolytic pathway in muscle tissue from patients with cancer. Cancer-induced muscle catabolism may at least in part reflect ubiquitin-proteasome-dependent protein breakdown.
引用
收藏
页码:744 / 749
页数:6
相关论文
共 25 条
  • [1] Attaix D, 1998, ADV MOL CEL, V27, P235, DOI 10.1016/S1569-2558(08)60463-4
  • [2] ACTIVATION OF THE ATP-UBIQUITIN-PROTEASOME PATHWAY IN SKELETAL-MUSCLE OF CACHECTIC RATS BEARING A HEPATOMA
    BARACOS, VE
    DEVIVO, C
    HOYLE, DHR
    GOLDBERG, AL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 268 (05): : E996 - E1006
  • [3] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [4] No alteration in gene expression of components of the ubiquitin-proteasome proteolytic pathway in dystrophin-deficient muscles
    Combaret, L
    Taillandier, D
    Voisin, L
    Samuels, SE
    BoespflugTanguy, O
    Attaix, D
    [J]. FEBS LETTERS, 1996, 393 (2-3): : 292 - 296
  • [5] FANG CH, 1995, J AM COLL SURGEONS, V180, P161
  • [6] The ubiquitin-proteasome pathway - Review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions
    Hasselgren, PO
    Fischer, JE
    [J]. ANNALS OF SURGERY, 1997, 225 (03) : 307 - 316
  • [7] Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats
    Llovera, M
    Carbo, N
    GarciaMartinez, C
    Costelli, P
    Tessitore, L
    Baccino, FM
    Agell, N
    Bagby, GJ
    LopezSoriano, F
    Argiles, JM
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) : 653 - 655
  • [8] LLovera M, 1998, INT J MOL MED, V2, P69
  • [9] Mechanism of muscle protein degradation induced by a cancer cachectic factor
    Lorite, MJ
    Thompson, MG
    Drake, JL
    Carling, G
    Tisdale, MJ
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (07) : 850 - 856
  • [10] LUPAS A, 1998, UBIQUITIN BIOL CELL, P127